TAK-861-3003 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A Double-blind, Placebo-Controlled, Randomized Withdrawal Trial to Evaluate the
Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy
(Narcolepsy Type 1)
Principal Investigator
Aatif M. Husain, MD
Epileptologist
Protocol Number
IRB:
PRO00119132
NCT:
NCT07363720
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment